Updates on HPV Vaccination

Cervical cancer still poses a significant global challenge. Developed countries have mitigated this challenge by the introduction of structured screening programmes and, more recently, the HPV vaccine. Countries that have successfully introduced national HPV vaccination programmes are on course for...

Full description

Bibliographic Details
Main Authors: Ojone Illah, Adeola Olaitan
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/2/243
_version_ 1797443857829330944
author Ojone Illah
Adeola Olaitan
author_facet Ojone Illah
Adeola Olaitan
author_sort Ojone Illah
collection DOAJ
description Cervical cancer still poses a significant global challenge. Developed countries have mitigated this challenge by the introduction of structured screening programmes and, more recently, the HPV vaccine. Countries that have successfully introduced national HPV vaccination programmes are on course for cervical cancer elimination in a few decades. In developing countries that lack structured screening and HPV vaccination programmes, cervical cancer remains a major cause of morbidity and mortality. The HPV vaccine is key to addressing the disproportionate distribution of cervical cancer incidence, with much to be gained from increasing vaccine coverage and uptake globally. This review covers the history and science of the HPV vaccine, its efficacy, effectiveness and safety, and some of the considerations and challenges posed to the achievement of global HPV vaccination coverage and the consequent elimination of cervical cancer.
first_indexed 2024-03-09T13:03:09Z
format Article
id doaj.art-cac6889e39cc465baadc867664e18688
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-09T13:03:09Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-cac6889e39cc465baadc867664e186882023-11-30T21:52:00ZengMDPI AGDiagnostics2075-44182023-01-0113224310.3390/diagnostics13020243Updates on HPV VaccinationOjone Illah0Adeola Olaitan1Women’s Cancer Department, EGA Institute for Women’s Health, University College London, London WC1E 6BT, UKWomen’s Cancer Department, EGA Institute for Women’s Health, University College London, London WC1E 6BT, UKCervical cancer still poses a significant global challenge. Developed countries have mitigated this challenge by the introduction of structured screening programmes and, more recently, the HPV vaccine. Countries that have successfully introduced national HPV vaccination programmes are on course for cervical cancer elimination in a few decades. In developing countries that lack structured screening and HPV vaccination programmes, cervical cancer remains a major cause of morbidity and mortality. The HPV vaccine is key to addressing the disproportionate distribution of cervical cancer incidence, with much to be gained from increasing vaccine coverage and uptake globally. This review covers the history and science of the HPV vaccine, its efficacy, effectiveness and safety, and some of the considerations and challenges posed to the achievement of global HPV vaccination coverage and the consequent elimination of cervical cancer.https://www.mdpi.com/2075-4418/13/2/243human papillomavirusHPVHPV vaccinecervical cancer
spellingShingle Ojone Illah
Adeola Olaitan
Updates on HPV Vaccination
Diagnostics
human papillomavirus
HPV
HPV vaccine
cervical cancer
title Updates on HPV Vaccination
title_full Updates on HPV Vaccination
title_fullStr Updates on HPV Vaccination
title_full_unstemmed Updates on HPV Vaccination
title_short Updates on HPV Vaccination
title_sort updates on hpv vaccination
topic human papillomavirus
HPV
HPV vaccine
cervical cancer
url https://www.mdpi.com/2075-4418/13/2/243
work_keys_str_mv AT ojoneillah updatesonhpvvaccination
AT adeolaolaitan updatesonhpvvaccination